Serveur d'exploration sur les protéines de liaison chez les plantes

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.

Identifieur interne : 000236 ( Main/Exploration ); précédent : 000235; suivant : 000237

Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.

Auteurs : Juan Reguera [France] ; Friedemann Weber ; Stephen Cusack

Source :

RBID : pubmed:20862319

Descripteurs français

English descriptors

Abstract

Bunyaviruses are a large family of segmented RNA viruses which, like influenza virus, use a cap-snatching mechanism for transcription whereby short capped primers derived by endonucleolytic cleavage of host mRNAs are used by the viral RNA-dependent RNA polymerase (L-protein) to transcribe viral mRNAs. It was recently shown that the cap-snatching endonuclease of influenza virus resides in a discrete N-terminal domain of the PA polymerase subunit. Here we structurally and functionally characterize a similar endonuclease in La Crosse orthobunyavirus (LACV) L-protein. We expressed N-terminal fragments of the LACV L-protein and found that residues 1-180 have metal binding and divalent cation dependent nuclease activity analogous to that of influenza virus endonuclease. The 2.2 A resolution X-ray crystal structure of the domain confirms that LACV and influenza endonucleases have similar overall folds and identical two metal binding active sites. The in vitro activity of the LACV endonuclease could be abolished by point mutations in the active site or by binding 2,4-dioxo-4-phenylbutanoic acid (DPBA), a known influenza virus endonuclease inhibitor. A crystal structure with bound DPBA shows the inhibitor chelating two active site manganese ions. The essential role of this endonuclease in cap-dependent transcription was demonstrated by the loss of transcriptional activity in a RNP reconstitution system in cells upon making the same point mutations in the context of the full-length LACV L-protein. Using structure based sequence alignments we show that a similar endonuclease almost certainly exists at the N-terminus of L-proteins or PA polymerase subunits of essentially all known negative strand and cap-snatching segmented RNA viruses including arenaviruses (2 segments), bunyaviruses (3 segments), tenuiviruses (4-6 segments), and orthomyxoviruses (6-8 segments). This correspondence, together with the well-known mapping of the conserved polymerase motifs to the central regions of the L-protein and influenza PB1 subunit, suggests that L-proteins might be architecturally, and functionally equivalent to a concatemer of the three orthomyxovirus polymerase subunits in the order PA-PB1-PB2. Furthermore, our structure of a known influenza endonuclease inhibitor bound to LACV endonuclease suggests that compounds targeting a potentially broad spectrum of segmented RNA viruses, several of which are serious or emerging human, animal and plant pathogens, could be developed using structure-based optimisation.

DOI: 10.1371/journal.ppat.1001101
PubMed: 20862319
PubMed Central: PMC2940753


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.</title>
<author>
<name sortKey="Reguera, Juan" sort="Reguera, Juan" uniqKey="Reguera J" first="Juan" last="Reguera">Juan Reguera</name>
<affiliation wicri:level="3">
<nlm:affiliation>European Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>European Molecular Biology Laboratory, Grenoble Outstation, Grenoble</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Weber, Friedemann" sort="Weber, Friedemann" uniqKey="Weber F" first="Friedemann" last="Weber">Friedemann Weber</name>
</author>
<author>
<name sortKey="Cusack, Stephen" sort="Cusack, Stephen" uniqKey="Cusack S" first="Stephen" last="Cusack">Stephen Cusack</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20862319</idno>
<idno type="pmid">20862319</idno>
<idno type="doi">10.1371/journal.ppat.1001101</idno>
<idno type="pmc">PMC2940753</idno>
<idno type="wicri:Area/Main/Corpus">000227</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000227</idno>
<idno type="wicri:Area/Main/Curation">000227</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000227</idno>
<idno type="wicri:Area/Main/Exploration">000227</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.</title>
<author>
<name sortKey="Reguera, Juan" sort="Reguera, Juan" uniqKey="Reguera J" first="Juan" last="Reguera">Juan Reguera</name>
<affiliation wicri:level="3">
<nlm:affiliation>European Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>European Molecular Biology Laboratory, Grenoble Outstation, Grenoble</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Weber, Friedemann" sort="Weber, Friedemann" uniqKey="Weber F" first="Friedemann" last="Weber">Friedemann Weber</name>
</author>
<author>
<name sortKey="Cusack, Stephen" sort="Cusack, Stephen" uniqKey="Cusack S" first="Stephen" last="Cusack">Stephen Cusack</name>
</author>
</analytic>
<series>
<title level="j">PLoS pathogens</title>
<idno type="eISSN">1553-7374</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence (MeSH)</term>
<term>Aminobutyrates (metabolism)</term>
<term>Bunyaviridae (enzymology)</term>
<term>Bunyaviridae (genetics)</term>
<term>Bunyaviridae Infections (genetics)</term>
<term>Bunyaviridae Infections (metabolism)</term>
<term>Bunyaviridae Infections (virology)</term>
<term>Catalytic Domain (MeSH)</term>
<term>Crystallization (MeSH)</term>
<term>Crystallography, X-Ray (MeSH)</term>
<term>DNA-Directed RNA Polymerases (chemistry)</term>
<term>DNA-Directed RNA Polymerases (genetics)</term>
<term>DNA-Directed RNA Polymerases (metabolism)</term>
<term>Endonucleases (chemistry)</term>
<term>Endonucleases (genetics)</term>
<term>Endonucleases (metabolism)</term>
<term>Humans (MeSH)</term>
<term>Influenza, Human (genetics)</term>
<term>Influenza, Human (virology)</term>
<term>Molecular Sequence Data (MeSH)</term>
<term>Orthomyxoviridae (genetics)</term>
<term>Orthomyxoviridae (immunology)</term>
<term>Orthomyxoviridae (metabolism)</term>
<term>Phenylbutyrates (MeSH)</term>
<term>Protein Structure, Tertiary (MeSH)</term>
<term>RNA Caps (genetics)</term>
<term>RNA Caps (metabolism)</term>
<term>RNA, Messenger (genetics)</term>
<term>RNA, Messenger (metabolism)</term>
<term>RNA, Viral (genetics)</term>
<term>RNA, Viral (metabolism)</term>
<term>Sequence Homology, Amino Acid (MeSH)</term>
<term>Transcription, Genetic (MeSH)</term>
<term>Viral Proteins (chemistry)</term>
<term>Viral Proteins (genetics)</term>
<term>Viral Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN messager (génétique)</term>
<term>ARN messager (métabolisme)</term>
<term>ARN viral (génétique)</term>
<term>ARN viral (métabolisme)</term>
<term>Amino-butyrates (métabolisme)</term>
<term>Bunyaviridae (enzymologie)</term>
<term>Bunyaviridae (génétique)</term>
<term>Coiffes des ARN (génétique)</term>
<term>Coiffes des ARN (métabolisme)</term>
<term>Cristallisation (MeSH)</term>
<term>Cristallographie aux rayons X (MeSH)</term>
<term>DNA-directed RNA polymerases (composition chimique)</term>
<term>DNA-directed RNA polymerases (génétique)</term>
<term>DNA-directed RNA polymerases (métabolisme)</term>
<term>Domaine catalytique (MeSH)</term>
<term>Données de séquences moléculaires (MeSH)</term>
<term>Endonucleases (composition chimique)</term>
<term>Endonucleases (génétique)</term>
<term>Endonucleases (métabolisme)</term>
<term>Grippe humaine (génétique)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains (MeSH)</term>
<term>Infections à Bunyaviridae (génétique)</term>
<term>Infections à Bunyaviridae (métabolisme)</term>
<term>Infections à Bunyaviridae (virologie)</term>
<term>Orthomyxoviridae (génétique)</term>
<term>Orthomyxoviridae (immunologie)</term>
<term>Orthomyxoviridae (métabolisme)</term>
<term>Phénylbutyrates (MeSH)</term>
<term>Protéines virales (composition chimique)</term>
<term>Protéines virales (génétique)</term>
<term>Protéines virales (métabolisme)</term>
<term>Similitude de séquences d'acides aminés (MeSH)</term>
<term>Structure tertiaire des protéines (MeSH)</term>
<term>Séquence d'acides aminés (MeSH)</term>
<term>Transcription génétique (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>DNA-Directed RNA Polymerases</term>
<term>Endonucleases</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA-Directed RNA Polymerases</term>
<term>Endonucleases</term>
<term>RNA Caps</term>
<term>RNA, Messenger</term>
<term>RNA, Viral</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Aminobutyrates</term>
<term>DNA-Directed RNA Polymerases</term>
<term>Endonucleases</term>
<term>RNA Caps</term>
<term>RNA, Messenger</term>
<term>RNA, Viral</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>DNA-directed RNA polymerases</term>
<term>Endonucleases</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Bunyaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Bunyaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Bunyaviridae</term>
<term>Bunyaviridae Infections</term>
<term>Influenza, Human</term>
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>ARN messager</term>
<term>ARN viral</term>
<term>Bunyaviridae</term>
<term>Coiffes des ARN</term>
<term>DNA-directed RNA polymerases</term>
<term>Endonucleases</term>
<term>Grippe humaine</term>
<term>Infections à Bunyaviridae</term>
<term>Orthomyxoviridae</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Bunyaviridae Infections</term>
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>ARN messager</term>
<term>ARN viral</term>
<term>Amino-butyrates</term>
<term>Coiffes des ARN</term>
<term>DNA-directed RNA polymerases</term>
<term>Endonucleases</term>
<term>Infections à Bunyaviridae</term>
<term>Orthomyxoviridae</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections à Bunyaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Bunyaviridae Infections</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Catalytic Domain</term>
<term>Crystallization</term>
<term>Crystallography, X-Ray</term>
<term>Humans</term>
<term>Molecular Sequence Data</term>
<term>Phenylbutyrates</term>
<term>Protein Structure, Tertiary</term>
<term>Sequence Homology, Amino Acid</term>
<term>Transcription, Genetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cristallisation</term>
<term>Cristallographie aux rayons X</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Phénylbutyrates</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Structure tertiaire des protéines</term>
<term>Séquence d'acides aminés</term>
<term>Transcription génétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Bunyaviruses are a large family of segmented RNA viruses which, like influenza virus, use a cap-snatching mechanism for transcription whereby short capped primers derived by endonucleolytic cleavage of host mRNAs are used by the viral RNA-dependent RNA polymerase (L-protein) to transcribe viral mRNAs. It was recently shown that the cap-snatching endonuclease of influenza virus resides in a discrete N-terminal domain of the PA polymerase subunit. Here we structurally and functionally characterize a similar endonuclease in La Crosse orthobunyavirus (LACV) L-protein. We expressed N-terminal fragments of the LACV L-protein and found that residues 1-180 have metal binding and divalent cation dependent nuclease activity analogous to that of influenza virus endonuclease. The 2.2 A resolution X-ray crystal structure of the domain confirms that LACV and influenza endonucleases have similar overall folds and identical two metal binding active sites. The in vitro activity of the LACV endonuclease could be abolished by point mutations in the active site or by binding 2,4-dioxo-4-phenylbutanoic acid (DPBA), a known influenza virus endonuclease inhibitor. A crystal structure with bound DPBA shows the inhibitor chelating two active site manganese ions. The essential role of this endonuclease in cap-dependent transcription was demonstrated by the loss of transcriptional activity in a RNP reconstitution system in cells upon making the same point mutations in the context of the full-length LACV L-protein. Using structure based sequence alignments we show that a similar endonuclease almost certainly exists at the N-terminus of L-proteins or PA polymerase subunits of essentially all known negative strand and cap-snatching segmented RNA viruses including arenaviruses (2 segments), bunyaviruses (3 segments), tenuiviruses (4-6 segments), and orthomyxoviruses (6-8 segments). This correspondence, together with the well-known mapping of the conserved polymerase motifs to the central regions of the L-protein and influenza PB1 subunit, suggests that L-proteins might be architecturally, and functionally equivalent to a concatemer of the three orthomyxovirus polymerase subunits in the order PA-PB1-PB2. Furthermore, our structure of a known influenza endonuclease inhibitor bound to LACV endonuclease suggests that compounds targeting a potentially broad spectrum of segmented RNA viruses, several of which are serious or emerging human, animal and plant pathogens, could be developed using structure-based optimisation.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20862319</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>02</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1553-7374</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>6</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2010</Year>
<Month>Sep</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>PLoS pathogens</Title>
<ISOAbbreviation>PLoS Pathog</ISOAbbreviation>
</Journal>
<ArticleTitle>Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.</ArticleTitle>
<Pagination>
<MedlinePgn>e1001101</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1001101</ELocationID>
<Abstract>
<AbstractText>Bunyaviruses are a large family of segmented RNA viruses which, like influenza virus, use a cap-snatching mechanism for transcription whereby short capped primers derived by endonucleolytic cleavage of host mRNAs are used by the viral RNA-dependent RNA polymerase (L-protein) to transcribe viral mRNAs. It was recently shown that the cap-snatching endonuclease of influenza virus resides in a discrete N-terminal domain of the PA polymerase subunit. Here we structurally and functionally characterize a similar endonuclease in La Crosse orthobunyavirus (LACV) L-protein. We expressed N-terminal fragments of the LACV L-protein and found that residues 1-180 have metal binding and divalent cation dependent nuclease activity analogous to that of influenza virus endonuclease. The 2.2 A resolution X-ray crystal structure of the domain confirms that LACV and influenza endonucleases have similar overall folds and identical two metal binding active sites. The in vitro activity of the LACV endonuclease could be abolished by point mutations in the active site or by binding 2,4-dioxo-4-phenylbutanoic acid (DPBA), a known influenza virus endonuclease inhibitor. A crystal structure with bound DPBA shows the inhibitor chelating two active site manganese ions. The essential role of this endonuclease in cap-dependent transcription was demonstrated by the loss of transcriptional activity in a RNP reconstitution system in cells upon making the same point mutations in the context of the full-length LACV L-protein. Using structure based sequence alignments we show that a similar endonuclease almost certainly exists at the N-terminus of L-proteins or PA polymerase subunits of essentially all known negative strand and cap-snatching segmented RNA viruses including arenaviruses (2 segments), bunyaviruses (3 segments), tenuiviruses (4-6 segments), and orthomyxoviruses (6-8 segments). This correspondence, together with the well-known mapping of the conserved polymerase motifs to the central regions of the L-protein and influenza PB1 subunit, suggests that L-proteins might be architecturally, and functionally equivalent to a concatemer of the three orthomyxovirus polymerase subunits in the order PA-PB1-PB2. Furthermore, our structure of a known influenza endonuclease inhibitor bound to LACV endonuclease suggests that compounds targeting a potentially broad spectrum of segmented RNA viruses, several of which are serious or emerging human, animal and plant pathogens, could be developed using structure-based optimisation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Reguera</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>European Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weber</LastName>
<ForeName>Friedemann</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cusack</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>09</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS Pathog</MedlineTA>
<NlmUniqueID>101238921</NlmUniqueID>
<ISSNLinking>1553-7366</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C515357">2,4-dioxo-4-phenylbutanoic acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000613">Aminobutyrates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C069882">L protein, Bunyamwera virus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010654">Phenylbutyrates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012315">RNA Caps</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.6</RegistryNumber>
<NameOfSubstance UI="D012321">DNA-Directed RNA Polymerases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance UI="D004720">Endonucleases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000613" MajorTopicYN="N">Aminobutyrates</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002043" MajorTopicYN="N">Bunyaviridae</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002044" MajorTopicYN="N">Bunyaviridae Infections</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003460" MajorTopicYN="N">Crystallization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012321" MajorTopicYN="N">DNA-Directed RNA Polymerases</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004720" MajorTopicYN="N">Endonucleases</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010654" MajorTopicYN="N">Phenylbutyrates</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012315" MajorTopicYN="N">RNA Caps</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014158" MajorTopicYN="Y">Transcription, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2010</Year>
<Month>08</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>2</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20862319</ArticleId>
<ArticleId IdType="doi">10.1371/journal.ppat.1001101</ArticleId>
<ArticleId IdType="pmc">PMC2940753</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Virology. 2004 Mar 30;321(1):29-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15033562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Phytopathol. 1998;36:139-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15012496</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Struct Biol. 2007;7:40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17584917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2005 Mar;150(3):533-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15503219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Apr 16;458(7240):914-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19194459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2007 Apr;88(Pt 4):1337-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17374780</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Biochem. 2006 Oct 15;357(2):289-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16962548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Apr 16;458(7240):909-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19194458</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2001 May 15;20(10):2545-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11350944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2008 Jun;78(3):194-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18258312</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2007 Dec 13;2(6):404-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18078692</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1995 Sep;69(9):5754-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7637020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1993 Oct;74 ( Pt 10):2293-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8409954</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Retrovirology. 2009;6:25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19265512</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Nov;83(22):11599-606</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19726499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Sep;84(18):9096-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20592097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 1994 Dec;38(12):2827-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7695269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Struct Mol Biol. 2008 May;15(5):500-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18454157</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 1996 May;40(5):1189-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8723464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Curr. 2009 Oct 13;1:RRN1052</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20025206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1984 Oct;52(1):215-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6481853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1990 Jan;174(1):53-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2294647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2007;152(10):1917-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17585367</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15299926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2003 Mar;92(1):99-105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12606081</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Struct Biol. 1999 May;6(5):458-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10331874</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1998 Aug;79 ( Pt 8):2051-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9714257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1994 Jun;75 ( Pt 6):1345-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7515937</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Sep;83(18):9024-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19587036</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Crystallogr D Biol Crystallogr. 1999 Apr;55(Pt 4):938-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10089341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 1983 Sep 24;11(18):6409-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6312422</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Chem. 2003 Mar 27;46(7):1153-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12646026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1981 Mar;23(3):847-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6261960</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2004 Jan 5;318(1):153-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14972544</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2003 May;84(Pt 5):1207-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12692286</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 2000 Feb;25(2):50-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10664582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Methods Enzymol. 1997;277:505-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18488322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2009;154(11):1719-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19777155</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Feb;84(4):1934-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20007273</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2004 Mar 30;321(1):23-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15033561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1373-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11567148</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 1994 Nov 11;22(22):4673-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7984417</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Struct Biol. 2010 Feb;20(1):104-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20061134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioinformatics. 1999 Apr;15(4):305-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10320398</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19294-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19047634</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 May 14;99(10):6661-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11997448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Methods Mol Biol. 2007;364:215-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17172768</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1998 Oct 23;273(43):27960-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9774410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2010 Mar 11;464(7286):232-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20118915</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement>
<li>Grenoble</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Cusack, Stephen" sort="Cusack, Stephen" uniqKey="Cusack S" first="Stephen" last="Cusack">Stephen Cusack</name>
<name sortKey="Weber, Friedemann" sort="Weber, Friedemann" uniqKey="Weber F" first="Friedemann" last="Weber">Friedemann Weber</name>
</noCountry>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Reguera, Juan" sort="Reguera, Juan" uniqKey="Reguera J" first="Juan" last="Reguera">Juan Reguera</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/MetalBindProtPlantV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000236 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000236 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    MetalBindProtPlantV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:20862319
   |texte=   Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20862319" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MetalBindProtPlantV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Nov 20 11:03:59 2020. Site generation: Fri Nov 20 11:04:44 2020